| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Chief Executive Officer | Stock Option (Right to Buy) | 288K | $12.7M | $43.95 | 23 Feb 2025 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Common Stock | 642K | $9.85M | $15.36 | 23 Feb 2025 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Performance Stock Unit | 172K | $2.65M | $15.36 | 23 Feb 2025 | Direct |
| QuidelOrtho Corp | Director | Common Stock | 33.3K | $2.31M | $69.22 | 06 Jun 2023 | By Trust |
| NEOGENOMICS INC | Chief Executive Officer | Restricted Stock Unit | 115K | $1.76M | $15.36 | 23 Feb 2025 | Direct |
| NEOGENOMICS INC | Chief Executive Officer | Restricted Stock Unit | 96.1K | $1.43M | $14.86 | 11 May 2024 | Direct |
| QuidelOrtho Corp | Director | Common Stock | 2.25K | $156K | $69.22 | 06 Jun 2023 | Direct |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | Common Stock | 54.1K | $110K | $2.03 | 30 Jan 2025 | Direct |
| QuidelOrtho Corp | Director | Restricted Stock Units (Converted) | 402 | $27.5K | $68.51 | 24 May 2023 | Direct |
| QuidelOrtho Corp | Director | Restricted Stock Units (Premium) | 80 | $5.48K | $68.51 | 24 May 2023 | Direct |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | Stock Option (right to buy) | 32.5K | 04 Jun 2025 | Direct | ||
| Akouos, Inc. | Director | Stock Option (right to buy) | 16K | 23 Jun 2022 | Direct | ||
| Ortho Clinical Diagnostics Holdings plc | Chairman and CEO, Director | Ordinary Shares, $0.00001 par value | 0 | $18.77 | 27 May 2022 | Direct | |
| Ortho Clinical Diagnostics Holdings plc | Chairman and CEO, Director | Stock Option | 0 | 27 May 2022 | Direct | ||
| QuidelOrtho Corp | Director | Restricted Stock Units (Equity Grant) | 0 | 06 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:06 |
| NEO | NEOGENOMICS INC | 23 Feb 2025 | 3 | $0 | 4 | Chief Executive Officer | 25 Feb 2025, 16:37 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 30 Jan 2025 | 2 | $0 | 4 | Director | 03 Feb 2025, 19:22 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 30 Jan 2025 | 0 | $0 | 3 | Director | 03 Feb 2025, 19:18 |
| NEO | NEOGENOMICS INC | 15 Aug 2024 | 1 | $0 | 4 | Chief Executive Officer | 19 Aug 2024, 16:19 |
| NEO | NEOGENOMICS INC | 11 May 2024 | 3 | -$281K | 4/A | Chief Executive Officer | 04 Dec 2024, 16:09 |
| NEO | NEOGENOMICS INC | 23 Feb 2024 | 3 | $0 | 4 | Chief Executive Officer | 27 Feb 2024, 16:28 |
| QDEL | QuidelOrtho Corp | 06 Jun 2023 | 2 | $0 | 4 | Director | 08 Jun 2023, 16:29 |
| QDEL | QuidelOrtho Corp | 27 May 2023 | 1 | -$105K | 4 | Director | 31 May 2023, 16:05 |
| QDEL | QuidelOrtho Corp | 24 May 2023 | 3 | $0 | 4 | Director | 25 May 2023, 20:21 |
| NEO | NEOGENOMICS INC | 11 May 2023 | 3 | $0 | 4 | Chief Executive Officer | 15 May 2023, 17:07 |
| NEO | NEOGENOMICS INC | 15 Aug 2022 | 3 | $0 | 4 | Chief Executive Officer | 17 Aug 2022, 19:13 |
| NEO | NEOGENOMICS INC | 15 Aug 2022 | 0 | $0 | 3 | Chief Executive Officer | 17 Aug 2022, 19:11 |
| AKUS | Akouos, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:05 |
| QDEL | QuidelOrtho Corp | 06 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 18:20 |
| QDEL | QuidelOrtho Corp | 27 May 2022 | 1 | $0 | 4/A | Director | 01 Aug 2022, 19:17 |
| QDEL | QuidelOrtho Corp | 27 May 2022 | 0 | $0 | 3 | Director | 01 Jun 2022, 16:59 |
| OCDX | Ortho Clinical Diagnostics Holdings plc | 27 May 2022 | 2 | $0 | 4 | Chairman and CEO, Director | 01 Jun 2022, 16:15 |
| OCDX | Ortho Clinical Diagnostics Holdings plc | 03 Jan 2022 | 3 | -$854K | 4 | Chairman and CEO, Director | 05 Jan 2022, 15:23 |
| OCDX | Ortho Clinical Diagnostics Holdings plc | 02 Aug 2021 | 3 | -$5.89M | 4 | Chairman and CEO, Director | 04 Aug 2021, 18:29 |
| AKUS | Akouos, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 16:35 |